![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Sponsors and Collaborators: |
Mitsubishi Tanabe Pharma Corporation Vertex Pharmaceuticals Incorporated |
---|---|
Information provided by: | Mitsubishi Tanabe Pharma Corporation |
ClinicalTrials.gov Identifier: | NCT00621296 |
The purpose of this study is to assess the efficacy and safety after administration of MP-424 to patients with chronic hepatitis C.
Condition | Intervention | Phase |
---|---|---|
Hepatitis C |
Drug: MP-424 |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Phase II Study of MP-424 in Patients With Genotype 1b Hepatitis C |
Estimated Enrollment: | 16 |
Study Start Date: | January 2008 |
Estimated Study Completion Date: | September 2009 |
Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 20 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Clinical Trials Information Desk | cti-inq-ml@ml.mt-pharma.co.jp |
Japan, Hokkaido | |
Sapporo-Kosei General Hospital | Recruiting |
Sapporo-city, Hokkaido, Japan |
Study Director: | Kazuoki Kondo, MD | Mitsubishi Tanabe Pharma Corporation |
Study Director: | Tadashi Yoshida, MD | Mitsubishi Tanabe Pharma Corporation |
Responsible Party: | Mitsubishi Tanabe Pharma Corporation ( General Manager, Clinical Research Department II ) |
Study ID Numbers: | G060-A7 |
Study First Received: | February 12, 2008 |
Last Updated: | August 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00621296 History of Changes |
Health Authority: | Japan: Ministry of Health, Labor and Welfare |
Chronic Hepatitis C Protease Inhibitor |
Virus Diseases Hepatitis Liver Diseases Digestive System Diseases Hepatitis, Chronic |
Hepatitis, Viral, Human Hepatitis C Hepatitis C, Chronic Protease Inhibitors |
Virus Diseases Hepatitis RNA Virus Infections Liver Diseases Digestive System Diseases |
Flaviviridae Infections Hepatitis, Chronic Hepatitis, Viral, Human Hepatitis C Hepatitis C, Chronic |